I'm going to try and call the SEC and FINRA to get definitive answers early Monday morning, before the market opens.
They say it's 25% of the securities value. Regen Biopharma has 500 million authorized shares and 51.9 million outstanding shares. The question is how the security is valued, based on A/S or O/S, or some other factor.
The opinions, comments, or concerns, expressed herein, are solely that of the screen name 'd5wr59mfi8'. They are not to be misconstrued as legal or financial advice and should not be followed. For financial advice, please see the guidance of financial p